Publicaciones en las que colabora con Ramón Luis Díaz García (25)

2023

  1. If You're Not Confused, You're Not Paying Attention: Ochrobactrum Is Not Brucella

    Journal of clinical microbiology, Vol. 61, Núm. 8, pp. e0043823

2017

  1. Poor performance of the rapid test for human brucellosis in health facilities in Kenya

    PLoS Neglected Tropical Diseases, Vol. 11, Núm. 4

2005

  1. Efficacy of several serological tests and antigens for diagnosis of bovine brucellosis in the presence of false-positive serological results due to Yersinia enterocolitica O:9

    Clinical and Diagnostic Laboratory Immunology, Vol. 12, Núm. 1, pp. 141-151

2001

  1. Promotion of platelet aggregation by sera from brucellosis patients with antiphosphatidylcholine antibodies

    Journal of Medical Microbiology, Vol. 50, Núm. 11, pp. 965-968

1998

  1. Anti-phosphatidylcholine antibodies in patients with brucellosis

    Journal of Medical Microbiology, Vol. 47, Núm. 1, pp. 49-54

  2. Evaluation of the relatedness of Brucella spp. and Ochrobactrum anthropi and description of Ochrobactrum intermedium sp. nov., a new species with a closer relationship to Brucella spp.

    International Journal of Systematic Bacteriology, Vol. 48, Núm. 3, pp. 759-768

1997

  1. Protective effect of liposomal gentamicin against systemic acute murine brucellosis

    Chemotherapy, Vol. 43, Núm. 3, pp. 204-210

1996

  1. Effect of composition and method of preparation of liposomes on their stability and interaction with murine monocytes infected with Brucella abortus

    Antimicrobial Agents and Chemotherapy, Vol. 40, Núm. 1, pp. 146-151

  2. Liposomas. Aplicaciones en terapia antimicrobiana y en inmunoprofilaxis

    REVISTA DE MEDICINA DE LA UNIVERSIDAD DE NAVARRA, Vol. 40, Núm. 2, pp. 100-109

1995

  1. Antibiotic treatment induces an increase of the specific antibody levels in Brucella melitensis infected mice

    FEMS Immunology and Medical Microbiology, Vol. 12, Núm. 2, pp. 91-95

  2. Coagglutination with antisera to MyfA and PsaA to distinguish Yersinia enterocolitica from Yersinia pseudotuberculosis pathogenic isolates.

    Contributions to microbiology and immunology, Vol. 13, pp. 158-164

  3. Comparative activity of azithromycin and doxycycline against brucella spp. infection in mice

    Journal of Antimicrobial Chemotherapy, Vol. 36, Núm. 4, pp. 647-656

  4. Evaluation of PCR and indirect enzyme-linked immunosorbent assay on milk samples for diagnosis of brucellosis in dairy cattle

    Journal of Clinical Microbiology, Vol. 33, Núm. 12, pp. 3198-3200

  5. Protective effect of Brucella outer membrane complex-bearing liposomes against experimental murine brucellosis

    FEMS Microbiology Letters, Vol. 130, Núm. 2-3, pp. 231-236

  6. Significance of environmental conditions (pH and serum) on the in vitro potency of azithromycin against Brucella melitensis

    Journal of Chemotherapy

1993

  1. Brucella group 3 outer membrane proteins contain a heat-modifiable protein

    FEMS Microbiology Letters, Vol. 112, Núm. 2, pp. 141-145

  2. Evaluation of whole cell and subcellular vaccines against Brucella ovis in rams

    Veterinary Immunology and Immunopathology, Vol. 37, Núm. 3-4, pp. 257-270

  3. Factors affecting detection of Brucella melitensis by BACTEC NR730, a nonradiometric system for hemocultures

    Journal of Clinical Microbiology, Vol. 31, Núm. 12, pp. 3200-3203

  4. The Myf fibrillae of Yersinia enterocolitica

    Molecular Microbiology, Vol. 9, Núm. 3, pp. 507-520

1992

  1. AISLAMIENTO DE YERSINIA ENTEROCOLITICA 0:8 EN ESPANA

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 10, Núm. 5, pp. 284-285